What is the intramuscular equivalent dose of 10 mg oral lorazepam (Ativan)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

IM Lorazepam Dose Equivalent to 10 mg Oral

The intramuscular equivalent of 10 mg oral lorazepam is approximately 5 mg IM, based on the roughly 2:1 oral-to-parenteral bioavailability ratio.

Bioavailability and Route Conversion

Lorazepam demonstrates 90% absolute bioavailability when given orally 1. However, the critical distinction lies in the pharmacokinetic profiles between routes:

  • Oral lorazepam: Peak plasma concentrations occur at approximately 2 hours, with absorption half-life averaging 28-33 minutes 2
  • IM lorazepam: Absorption is more rapid with peak levels at 1.15 hours and absorption half-life of approximately 14 minutes 2
  • Systemic availability: IM administration achieves 95.9% bioavailability compared to oral's 99.8%, making them essentially equivalent 2

Practical Dosing Conversion

Despite near-equivalent bioavailability, clinical practice typically uses a 2:1 oral-to-parenteral conversion ratio due to:

  1. Faster onset with IM route: The more rapid absorption and earlier peak effect mean lower doses achieve comparable clinical effects 3, 4
  2. Prolonged sedative effects: Even with IV administration, maximum sedative effect is delayed 30-40 minutes, with drowsiness persisting at least 4 hours 3

Recommended Conversion for 10 mg Oral:

  • IM dose: 4-5 mg (not exceeding 5 mg as maximum single dose per guidelines)

Critical Safety Considerations

Important caveats when using IM lorazepam:

  • Pain at injection site: IM administration causes high frequency of injection site pain and restlessness persisting 20-40 minutes 3
  • Maximum single dose: Guidelines specify 5 mg maximum single dose for IM/IV routes 5
  • Respiratory depression risk: Increased apnea incidence when combined with other sedatives; prepare for respiratory support 5
  • Prolonged duration: One-third of peak concentration remains in blood at 24 hours regardless of route 4

Clinical Algorithm for Route Selection

Choose IM over oral when:

  • Rapid onset needed (1.15 hours vs 2+ hours to peak)
  • Patient unable to take oral medications
  • Acute agitation requiring faster control

Avoid IM route if:

  • Patient can tolerate oral (less pain, equal efficacy at 2+ hours)
  • Outpatient setting (prolonged sedation inappropriate) 6
  • Expected hospital stay <72 hours 6

Monitoring Requirements

Regardless of route with this dose range:

  • Monitor oxygen saturation continuously 5
  • Prepare for respiratory support - have flumazenil available if life-threatening depression occurs 5
  • Observe for paradoxical agitation 5
  • Assess for hypotension, particularly in unstable patients 5

Bottom line: For 10 mg oral lorazepam, use 5 mg IM as the maximum safe equivalent dose, recognizing this provides comparable or greater clinical effect due to faster absorption kinetics, while staying within established safety parameters.

Related Questions

Is a 1 mg oral dose of lorazepam (Ativan) equivalent to a 1 mg intravenous dose?
In a healthy 34-year-old adult, is a single 2 mg sublingual dose of lorazepam considered a high dose?
What is the appropriate intramuscular dose of lorazepam (Ativan) for an adult patient?
How should lorazepam (Ativan) be administered intramuscularly, including appropriate dosing, injection site, and safety precautions?
How can I prescribe a 0.25 mg dose of lorazepam for a 70‑year‑old female when the tablets are not available in that strength?
Is the vaccine mFLUSIVA (high‑dose quadrivalent influenza vaccine) more likely to have fewer side effects than a standard‑dose influenza vaccine, and is it indicated for adults aged 50 years and older?
What are the possible causes and recommended management for afternoon headaches in an adult without red‑flag features?
Is it dangerous to receive a COVID‑19 vaccine 2–4 weeks after recovering from COVID‑19?
Can you provide a detailed comparison of the current and previous sepsis management guidelines?
What is the appropriate daily dosing regimen for Suboxone (buprenorphine/naloxone) and what is the maximum recommended dose?
Which of the following medications—sodium chloride 0.9% infusion 50 mL/hr three times daily, sulfamethoxazole‑trimethoprim 800/160 mg daily, duloxetine 60 mg every 12 hours, oxycodone 5 mg as needed, levofloxacin 250 mg daily, lisinopril 5 mg daily, midodrine 10 mg three times daily, bictegravir/emtricitabine/tenofovir alafenamide (Biktarvy) daily, metoprolol succinate extended‑release 25 mg daily, acetaminophen 325 mg two tablets as needed, pregabalin 100 mg twice daily, topiramate 50 mg twice daily, fluticasone‑salmeterol inhalation, tiotropium inhalation, nystatin‑triamcinolone cream, nystatin powder, levothyroxine 100 µg daily, atorvastatin 80 mg at bedtime, bisacodyl suppository 10 mg as needed, fleet enema as needed, pantoprazole 40 mg twice daily, ipratropium‑albuterol solution as needed, sumatriptan 50 mg as needed, and albuterol‑budesonide inhaler as needed—have the potential to affect kidney function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.